Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12 ; volume:72 ; number:8 ; day:11 ; month:5 ; year:2023 ; pages:2783-2797 ; date:8.2023
Cancer immunology immunotherapy ; 72, Heft 8 (11.5.2023), 2783-2797, 8.2023
- Creator
-
Franks, S. Elizabeth
Santiago-Sanchez, Ginette S.
Fabian, Kellsye P.
Solocinski, Kristen
Chariou, Paul L.
Hamilton, Duane H.
Kowalczyk, Joshua T.
Padget, Michelle R.
Gameiro, Sofia R.
Schlom, Jeffrey
Hodge, James W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03459-7
- URN
-
urn:nbn:de:101:1-2023102609412116652387
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Franks, S. Elizabeth
- Santiago-Sanchez, Ginette S.
- Fabian, Kellsye P.
- Solocinski, Kristen
- Chariou, Paul L.
- Hamilton, Duane H.
- Kowalczyk, Joshua T.
- Padget, Michelle R.
- Gameiro, Sofia R.
- Schlom, Jeffrey
- Hodge, James W.
- SpringerLink (Online service)
Other Objects (12)
Targeted lipid-coated nanoparticles : delivery of tumor necrosis factor-functionalized particles to tumor cells
Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
Molecular cloning, analysis and targeted disruption of the mouse tumor necrosis factor receptor genes
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Tumor necrosis factor, cachectin and related cytokines
Golimumab: A Novel Anti-Tumor Necrosis Factor
Tongue swelling and necrosis after brain tumor surgery
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression
Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis
Targeted lipid-coated nanoparticles : delivery of tumor necrosis factor-functionalized particles to tumor cells
Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
Molecular cloning, analysis and targeted disruption of the mouse tumor necrosis factor receptor genes
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Tumor necrosis factor, cachectin and related cytokines
Golimumab: A Novel Anti-Tumor Necrosis Factor
Tongue swelling and necrosis after brain tumor surgery
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression
Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis
Targeted lipid-coated nanoparticles : delivery of tumor necrosis factor-functionalized particles to tumor cells
Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
Molecular cloning, analysis and targeted disruption of the mouse tumor necrosis factor receptor genes
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Tumor necrosis factor, cachectin and related cytokines
Golimumab: A Novel Anti-Tumor Necrosis Factor
Tongue swelling and necrosis after brain tumor surgery
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression